By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use.  I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

About the Team: 

The U.S. Foundational Therapies Platform (FTP) Business Unit brings together Takeda’s longstanding Immunology, Hematology, Lysosomal Storage Disorders (LSD), Alpha-1 Antitrypsin Deficiency and Transplant portfolios to support patients who rely on treatment over the long term, often for years or decades. United by a shared focus on continuity of care, reliability and sustained partnership, FTP is designed to deliver the foundational capabilities patients, caregivers and healthcare providers depend on at scale. 

You will join a culture grounded in collaboration, accountability, and respect for the patient experience. Working as one team, we connect patients and healthcare providers with the capabilities, teams and support necessary to deliver coordinated care across the healthcare ecosystem. 

The Rare Disease Business Manager (RDBM), leverages strong communication and interpersonal skills with an ability to analyze data and translate into actionable strategies to assist HCPs in the acceleration diagnosis of patients within the rare metabolic space.  

The RDBM will establish and build impactful relationships with all physicians and accounts within their geographic responsibility by providing scientific data and in-depth knowledge where appropriate for the Takeda Rare Disease portfolio of Lysosomal Storage Disorder products.  

Through strategic data analysis and business planning, the RDBM will collaborate with multidisciplinary healthcare providers and internal stakeholders to provide educational resources and tools necessary to assist in early patient diagnosis and/or treatment. The RDBM will educate and raise awareness of specific Lysosomal Storage Disorders, Gaucher Disease and Hunters (MPS II) Syndrome, with health care providers in a defined geography. When appropriate, the RDBM will also partner with the cross functional members to integrate resources and help educate HCPs on facilitation of therapy for their patients. You will report to the Regional Business Director, LSD. 

Responsibilities: 

• You will be responsible for all business-related activities within their geographic responsibility, including achievement of sales goals through executing brand strategies.​

• The RDBM call points will primarily focus on target physicians seeing patients with Lysosomal Storage Disorders and assisting healthcare providers with the education necessary to aid in early diagnosis and/or treatment. 

• In-depth business planning allowing for partnership with the regional counterparts that allocates appropriate disease state & product education throughout their geography.  

• Advanced customer engagement to create disease state awareness within multidisciplinary health care specialties to enhance the LSD business and build support for the portfolio of products. 

• RDBM will educate